Particle Therapy

Particle Therapy Market by Therapy Type (Heavy Ion Therapy, Proton Therapy), Component (Product, Service), Configuration, Cancer Type, End-User - Global Forecast 2024-2030

360iResearch Analyst
Want to know more about the particle therapy market or any specific requirement? Ketan helps you find what you're looking for.
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[193 Pages Report] The Particle Therapy Market size was estimated at USD 772.41 million in 2023 and expected to reach USD 831.50 million in 2024, at a CAGR 7.94% to reach USD 1,318.87 million by 2030.

Particle Therapy Market
To learn more about this report, request a free PDF copy

The particle therapy forms a specific segment of the broader therapeutical technology. Primarily, it focuses on the global commercialization, distribution, and application of particle therapy technologies. Particle therapy utilizes charged and uncharged particles, such as protons and neutrons, within a controlled environment to target and eliminate cancer cells inside a patient's body. The effectiveness of this therapy in ensuring precision mainly drives market demand and growth. The increasing need for advanced therapies in cancer treatment and the rising adoption of particle therapy in clinical trials, fast, non-invasive, and painless procedures significantly contribute to driving this market growth. In contrast, limited insurance coverage for particle therapy and risk associated with particle therapy radiation exposure limits their utilization and penetrates the market growth. However, several vendors are developing more advanced and compact particle therapy systems and focusing on enhancing precision and minimizing potential side effects. Moreover, ongoing proton therapy research programs and technological advancements in charged-particle therapy are creating a myriad of opportunities for particle therapy expansion.

Particle Therapy Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Therapy Type: Consumer preference for proton therapy as it provides a reduced risk of damage to surrounding tissues

Heavy ion therapy employs densely ionized atoms such as carbon to initiate precise damage to cancer cells. The technique results in minimal damage to surrounding healthy tissue. This therapy is effective on radio-resistant tumors, providing an edge over traditional forms of radiotherapy. Proton therapy is increasingly preferred, especially in pediatrics, due to its damage-limiting property for surrounding tissues and organs, making a significant difference to patients with tumors near critical organs. Heavy ion therapy provides a promising solution for radio-resistant tumors, and proton therapy is often preferred for pediatric cancer patients because of its reduced risk of damage to surrounding tissues.

Component: Rising utilization of product components for treating solid tumors near vital organs due to their high accuracy

Particle therapy products primarily constitute equipment that delivers the target's particle beams. This includes machines such as cyclotrons, synchrocyclotrons, and synchrotrons. Cyclotrons are utilized to accelerate charged particles to high energies. Synchrocyclotrons are designed to overcome the frequency limitation of cyclotrons by altering the frequency of the accelerating electric field. This makes them ideal for particle therapy due to their ability to deliver high-energy beams effectively and accurately. Synchrotrons are particle accelerators but demonstrate more control over the energy of the accelerated particles, making them an excellent choice for particle therapy. They are often utilized in treating deep-seated and complex-shaped tumors. Particle therapy delivers high doses of radiation precisely to tumor cells and comes in different systems where each offers unique benefits depending upon the specific needs and situations of the healthcare establishment. The services segment includes installation, maintenance, training, and consulting services related to particle therapy systems. In comparison, the requirement for a product component is more imminent in countries with health institutes experiencing an influx of cancer patients and having the infrastructure to support a particle therapy unit. The service component's demand is more in countries where healthcare organizations are in the early stages of developing or planning to develop a particle therapy unit.

Configuration: Potential of a multi-room system for treating a larger number of patients concurrently

A multi-room system in particle therapy incorporates multiple treatment rooms, thus allowing more patients to receive treatment concurrently. These systems are immensely beneficial for large healthcare establishments, owing to the faster patient flow, the ability to treat complex cases, and the efficiency in maximizing the usage of particle accelerator facilities. Single-room systems are the ideal choice for smaller healthcare facilities that are starting to venture into the realm of particle therapy. They are generally easier to implement and manage due to the compact design and relatively simpler logistics. In comparison, multi-room systems are beneficial in treating a larger number of patients concurrently and cater to complex cases, and their implementation demands higher initial investment and operational complexity. On the contrary, single-room systems, with their compact design and manageable logistics, are easier to implement and operate, thus being a better fit for smaller healthcare facilities initiating their journey into particle therapy.

Cancer Type: Expanding usage of particle therapy for head & neck cancer owing to reduced risk on healthy tissue

Particle therapy, offering highly focused radiation, has brought about remarkable results in breast cancer management, especially for patients with recurring or aggressive forms of the disease. Particle therapy for head & neck cancer shows promising results due to the anatomical complexity of this region. The precise and high-dosage radiation from particle therapy minimizes the risk of excess radiation in healthy tissues around the tumor. Lung cancer, notorious for its resistance to traditional radiation therapy, has seen promising treatment outcomes through particle therapy. Particle therapy is considerably beneficial in treating pediatric cancers, reducing the long-term side effects usually associated with traditional radiation treatments. Prostate cancer treatment has been dramatically enhanced by particle therapy, given the highly effective and precise radiation techniques. In comparison, particle therapy has emerged as a new dawn in the field of head & neck cancer treatment, offering hope to patients battling various forms of the disease.

End-User: Significant role of particle therapy in hospitals & clinicals as they strive to provide high-quality care

Ambulatory surgery centers (ASCs) allow surgeons to deliver efficient, high-quality care at a lower cost. In particle therapy, these centers cater to instances where the cancer is well-defined and is treated in a few sessions. Hospitals and clinics offer more comprehensive care and cater to various cancer cases. They provide both proton and heavy ion therapies to treat a variety of cancers, including more complex issues. These institutions have large treatment facilities equipped with advanced particle therapy machines. Due to their nature of operation, ambulatory surgery centers embrace compact, streamlined designs best suited for less complex cases, striving for efficiency with limited space. Hospitals & clinics offer more robust treatment capabilities to manage various cases, from the simple to the complex.

Regional Insights

In America, the need for particle therapy has seen consistent growth. Technology innovation is frequent and heavily backed by both private and public organizations. This region holds the most significant market share due to extensive research activities and the rise of numerous startups funded by investors targeting therapy innovation. In the EMEA region, Europe exhibits formidable growth in particle therapy primarily due to the rising incidences of various cancer types and a growing elderly population at risk. Moreover, increased funding in healthcare from various governments and organizations, coupled with well-established healthcare facilities, allows for broader adoption of the technique. Middle Eastern and African countries also show promising growth, mainly due to rising healthcare expenditure and increased efforts to enhance healthcare infrastructure. In the APAC region, several economies are leading in adopting particle therapy for cancer treatment. Factors contributing to such progress include the increasing prevalence of cancer, rapid urbanization, and continually improving economic conditions. APAC offers a vast population base, which, combined with improving healthcare infrastructures and increasing government funding for cancer research and treatment, presents APAC as a fast-growing market for particle therapy.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Particle Therapy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Particle Therapy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • IBA and PARTICLE Initiate FLASH Proton Therapy Research Partnership

    IBA International and PARTICLE (Particle Therapy Interuniversity Center Leuven) have established a Research Partnership to develop ConformalFLASH in the context of Particle Therapy. This collaboration signifies another significant milestone in bringing FLASH therapy to patients in the clinic. [Published On: 2023-06-16]

  • P-Cure Receives FDA Approval For Proton Therapy System For Treatment in Seated Position and Will Begin Treating Patients In Israel

    P-Cure Ltd has obtained FDA clearance for its Adaptive Proton Therapy Solution in the USA. This solution represents the FDA-approved methodology for patient-ready cancer treatment. This FDA clearance represents a significant milestone in expanding the clinical benefits of proton therapy to medical facilities globally while also providing a cost-effective option for existing oncology centers. [Published On: 2023-04-03]

  • Terapet raises CHF 2.3 million for its next-generation cancer treatment technology

    CERN secured CHF 2.3 million in funding to develop particle therapy technology to enhance cancer treatments by delivering radiation doses with unparalleled precision and minimizing damage to healthy tissue. With this significant investment and the promising development of Qualγscan, Terapet is poised to make significant advancements in particle therapy technology, revolutionizing cancer treatment and improving patient outcomes. [Published On: 2023-02-27]

Key Company Profiles

The report delves into recent significant developments in the Particle Therapy Market, highlighting leading vendors and their innovative profiles. These include Advanced Oncotherapy plc, B dot Medical Inc., Best Particle Therapy, Inc., BioSig Technologies Inc., Covenant Health, Danfysik A/S, Elekta AB, Hitachi, Ltd., IBA International, Koninklijke Philips N.V., Mevion Medical Systems, Mitsubishi Electric Corporation, New Mexico Cancer Center, Optivus Proton Therapy, Inc., P-Cure Ltd, ProTom International, Provision Healthcare, LLC, PTW Freiburg GmbH, SAH Global LLC, Shanghai APACTRON Particle Equipment Co., Ltd., Siemens Healthineers GmbH, Stantec Inc., Sumitomo Heavy Industries, Ltd., Toshiba Medical Systems Corporation, and Xstrahl Ltd..

Market Segmentation & Coverage

This research report categorizes the Particle Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Therapy Type
    • Heavy Ion Therapy
    • Proton Therapy
  • Component
    • Product
      • Cyclotrons
      • Synchrocyclotrons
      • Synchrotrons
    • Service
  • Configuration
    • Multi-room System
    • Single-room System
  • Cancer Type
    • Breast Cancer
    • Head & Neck Cancer
    • Lung Cancer
    • Pediatric Cancer
    • Prostate Cancer
  • End-User
    • Ambulatory Surgery Centers
    • Hospitals & Clinics

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Particle Therapy Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Particle Therapy Market?
  3. What are the technology trends and regulatory frameworks in the Particle Therapy Market?
  4. What is the market share of the leading vendors in the Particle Therapy Market?
  5. Which modes and strategic moves are suitable for entering the Particle Therapy Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Particle Therapy Market, by Therapy Type
  7. Particle Therapy Market, by Component
  8. Particle Therapy Market, by Configuration
  9. Particle Therapy Market, by Cancer Type
  10. Particle Therapy Market, by End-User
  11. Americas Particle Therapy Market
  12. Asia-Pacific Particle Therapy Market
  13. Europe, Middle East & Africa Particle Therapy Market
  14. Competitive Landscape
  15. Competitive Portfolio
  16. List of Figures [Total: 26]
  17. List of Tables [Total: 552]
  18. List of Companies Mentioned [Total: 25]
Particle Therapy: The Future of Cancer Treatment
November 30, 2023
Particle Therapy: The Future of Cancer Treatment
Cancer is a major health concern worldwide. In recent years, advanced therapies have been developed to treat various types of cancer. One of these therapies is particle therapy, also known as proton or carbon ion therapy. It's a type of radiation therapy that uses high-energy protons or carbon ions to kill cancer cells. It has several benefits over traditional radiation therapy, including reduced side effects, improved accuracy, and shorter treatment duration. This blog discusses the scope of particle therapy in cancer treatment and its advantages.

Scope of Particle Therapy:

Particle therapy is a rapidly evolving field in cancer treatment. It has been used to treat various types of cancer, including brain tumors, prostate cancer, lung cancer, liver cancer, and more. The treatment involves a beam of high-energy particles that target cancer cells with great precision, sparing healthy tissues. This high accuracy allows for the treatment of tumors that were previously considered untreatable.

Advantages of Particle Therapy:

Particle therapy has several advantages over traditional radiation therapy. Firstly, it has a reduced risk of damaging healthy tissues, which reduces side effects. Secondly, it delivers a higher dose of radiation to the tumor, which increases the likelihood of killing cancer cells. Thirdly, it has a shorter treatment duration as compared to traditional radiation treatment. Lastly, it can be used to treat tumors that are close to critical organs or structures without damaging them.

Clinical Trials:

Particle therapy has been the topic of many clinical trials over the years. These trials have demonstrated the effectiveness of particle therapy in treating cancer patients. Currently, particle therapy is being used in many cancer treatment centers worldwide. Research is ongoing to explore its potential in the treatment of more types of cancer.

Cost of Particle Therapy:

One major drawback of particle therapy is its cost. It's a relatively new and expensive treatment modality, requiring specialized technology and personnel. The cost of particle therapy is much higher than traditional radiation therapy. However, with the advancement of technology and an increase in the number of particle therapy centers, it's hoped that the cost will decrease in the future, making it more accessible to patients.

Particle therapy is an advanced and promising therapy in cancer treatment. It has many advantages over traditional radiation therapy, including reduced side effects, improved accuracy, and shorter treatment duration. Its scope is expanding rapidly, and it's expected to become an increasingly important therapy in cancer treatment. Despite its high cost, it's hoped that with the advancement of technology and an increase in the number of particle therapy centers, it will become more accessible to patients in the future.

Frequently Asked Questions
  1. How big is the Particle Therapy Market?
    Ans. The Global Particle Therapy Market size was estimated at USD 772.41 million in 2023 and expected to reach USD 831.50 million in 2024.
  2. What is the Particle Therapy Market growth?
    Ans. The Global Particle Therapy Market to grow USD 1,318.87 million by 2030, at a CAGR of 7.94%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.